Onco-Innovations Ltd. (ONCO) Price & Analysis

20 Followers

ONCO Stock Chart & Stats

C$1.47

C$0.00(0.00%)

At close: Jul 24 4:00 PM EDT

C$1.47

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$1.45 - C$1.53

Previous CloseN/A

Volume0.00

Average Volume (3M)42.49K

Market Cap

C$101.76M

Enterprise ValueC$88.25

Total Cash (Recent Filing)C$1.41M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta0.62

Next Earnings

Dec 23, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding69,224,365

10 Day Avg. Volume32,154

30 Day Avg. Volume42,494

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Onco-Innovations Ltd. News

Onco-Innovations Converts Insider Debt to Equity in $481,694 Share Settlement

An update from Onco-Innovations Ltd. ( ($TSE:ONCO) ) is now available. Onco-Innovations Limited has closed a shares-for-debt settlement...

5d ago

Onco-Innovations Converts Insider Debt to Equity in C$481,694 Share Deal

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has shared an announcement. Onco-Innovations Limited has entered into agreements with certain insiders...

13d ago

Onco-Innovations Strikes LOI for Global Rights to Ifowonco’s Oral LAG-3 Inhibitor Program

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an update. Onco-Innovations has entered into a non-binding letter of intent...

1M ago

Onco-Innovations Advances ONC010 Manufacturing and Polymer Development for Future Clinical Trials

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an update. Onco-Innovations reported that Nanosoft Polymers has identified a non-tin...

1M ago

BlackRock Adjusts Stake in Caledonia Mining, Triggers Major Holding Disclosure

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an update. Caledonia Mining Corporation Plc has disclosed that asset manager...

2M ago

Onco-Innovations Sets Up Australian Subsidiary and Taps New Marketing Partner Ahead of Phase I Trials

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an announcement. Onco-Innovations has executed an engagement agreement with RDI Partners...

6M ago

Onco-Innovations Raises $1.22 Million in Completed Private Placement

The latest update is out from Onco-Innovations Ltd. ( ($TSE:ONCO) ). Onco-Innovations Limited has closed a non-brokered private...

6M ago

Onco-Innovations Seeks Up to $2 Million in Private Placement to Advance Cancer Research

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations Limited plans to raise up to $2 million...

7M ago

Onco-Innovations Revises Pricing on $2 Million Private Placement

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations has amended the pricing of its previously announced...

7M ago

Onco-Innovations Files Preliminary Base Shelf Prospectus to Boost Financing Flexibility

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an announcement. Onco-Innovations Limited has filed a preliminary base shelf prospectus...

8M ago

ONCO FAQ

What was Onco-Innovations Ltd.’s price range in the past 12 months?

Onco-Innovations Ltd. lowest stock price was C$1.45 and its highest was C$1.53 in the past 12 months.

What is Onco-Innovations Ltd.’s market cap?

Onco-Innovations Ltd.’s market cap is C$101.76M.

When is Onco-Innovations Ltd.’s upcoming earnings report date?

Onco-Innovations Ltd.’s upcoming earnings report date is Dec 23, 2026 which is in 92 days.

How were Onco-Innovations Ltd.’s earnings last quarter?

Onco-Innovations Ltd. released its earnings results on Sep 14, 2026. The company reported -C$0.056 earnings per share for the quarter.

Is Onco-Innovations Ltd. overvalued?

According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Onco-Innovations Ltd. pay dividends?

Onco-Innovations Ltd. does not currently pay dividends.

What is Onco-Innovations Ltd.’s EPS estimate?

Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Onco-Innovations Ltd. have?

Onco-Innovations Ltd. has 69,224,365 shares outstanding.

What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?

Onco-Innovations Ltd. reported an EPS of -C$0.056 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Onco-Innovations Ltd.?

Currently, no hedge funds are holding shares in TSE:ONCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Onco-Innovations Ltd. Stock Smart Score

Underperform

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

195.04%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Onco-Innovations Ltd.

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.